Loading … Related materials
Invented a device for remote fingerprinting
Scientists have learned to determine life expectancy by DNA
The world's first hangover-free alcohol appeared
To understand that death will occur within the next 5-10 years, it is enough to donate blood for amino acids. This conclusion was made by scientists from England and Finland.
Recently, a study by Brunel University in London was published, conducted in conjunction with a group of Finnish scientists from FINRISK. In England, 44 thousand people took part in the experiment, in Finland – 17 thousand, not only living, but also those who died in the past 10 years.
Scientists have studied the medical records of these people. A biochemical blood test for amino acids of 10 years ago was analyzed – all people selected as the object of study passed this analysis in 2009.
By the way, in Russia, a blood test for amino acids is not included in the category of common ones. You can donate blood for the main 32 amino acids in a commercial clinic for an average of 5 thousand rubles.
Most amino acids are markers of rare diseases, so Russian doctors are in no hurry to send patients for such an analysis. And, as it turned out, completely in vain. As the British with the Finns discovered, by the level of 6 amino acids, one can predict the death of a person in the next 5-10 years.
So what kind of tests do you need to have in order not to die in the next decade? To do this, your blood level of histidine, leucine or valine should be higher than normal. And while the concentration of glucose, lactate or phenylalanine should be normal.
If glucose, lactate or phenylalanine is below normal, then this is a sure sign that you will not live for more than 10 years. Thus, it turned out that a low concentration of glucose in the blood is a more dangerous phenomenon than a high glucose level.
However, even if you don’t donate blood for amino acids, the risk of dying can be estimated by other indicators. For example, high histidine levels are associated with high hemoglobin levels. That is, the higher your hemoglobin, the more likely it is to live to a very old age.
You can increase the level of histidine in the blood by frequent consumption of beans, red meat and salmon. Moreover, those people who had a low level of histidine in the blood later developed rheumatoid arthritis, leading to the destruction of joints and requiring replacement.
External signs of low histidine levels are pallor and a feeling of tiredness. Also, a feeling of fatigue can be an external indicator of another bad sign – a deficiency in the blood of phenylalanine. In addition, a lack of this amino acid leads to headaches and depression.
As the researchers note, the listed 6 amino acids equally affect the mortality of both men and women, and the patient’s age does not affect the causal relationship – the main thing is that he is more than 18 years old.
Interestingly, before this, the FINRISK group had already conducted studies related to the level of substances in the blood and mortality. So, in one study, they looked for a connection between low testosterone and mortality from heart disease – a similar relationship was previously announced in the West.
According to Western scientists, men with low testosterone often had more weight, hypertension, and diabetes. As a result, early mortality was prevalent in this group, primarily from heart disease.
However, the Finns, having examined the data of 7 thousand people, came to the conclusion that men with low testosterone do not die of heart disease more often than men with normal and high levels of male hormone.
Moreover, the Finns linked the theory of the dangers of low testosterone to the “medical mafia”. In their opinion, the legend of this danger was spreading with the goal of introducing testosterone replacement therapy (STT). Basically, such therapy was prescribed for elderly patients whose testosterone levels decreased with age.
As Finnish scientists discovered, men who were prescribed ZTT died of heart disease with the same frequency as men with low testosterone who were either not given this therapy or refused it.
By the way, in Russia, unlike the West, testosterone replacement therapy is not widespread: the Russian community of urologists considers ZTT a possible cause of prostate cancer.
In addition, Finnish scientists claim that low testosterone has little effect on obesity in men and is not associated with high blood pressure.